Management of Mild to Moderate Facial Acne Vulgaris

Comparative study on the efficacy and safety of Adapalene vs Benzoyl peroxide in patients with mild to moderate facial acne vulgaris in tertiary care hospital

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/04/033182

Enrollment

100

Registered

2021-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: 0.1% adapalene gel: 0.1% adapalene gel OD Control Intervention1: 2.5% benzoyl peroxide gel: 2.5% benzoyl peroxide gel OD

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both genders of age group between 13 to 40 years with mild to moderate facial acne vulgaris who are willing to participate in study were included

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Patient not willing to participate and not willing to come for follow-up Patients with drug induced acneiform eruptions Patients with history of allergy to adapalene and benzoyl peroxide Patients with pre-existing chronic systemic illness Patients with severe and cystic acne vulgaris

Design outcomes

Primary

Measure	Time frame
Effects of Adapalene and Benzoyl Peroxide in terms of lesion reduction will be evaluatedTimepoint: Baseline,4weeks,8weeks,12weeks	—

Secondary

Measure	Time frame
The side effects of Adapalene and Benzoyl peroxide will be assessedTimepoint: Baseline,4weeks,8weeks,12weeks	—

Countries

India

Contacts

Public ContactAshwini T

SREE BALAJI MEDICAL COLLEGE AND HOSPITAL

dr.gloryj@gmail.com9840230181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026